Q3 2026 capital expenditures $985M
Company: Core Scientific
The claim, verbatim
Capital expenditures totaled $985 million in the third quarter.
Source (primary)
Core Scientific Revenue Climbs to $232.9 Million on Colocation Growth - TOKENPOST (-, news_article)
View cached copy (2026-11-13)Live source ↗Archive.org ↗
Quote: “Capital expenditures totaled $985 million.”
How we checked this
Checked on November 14, 2026. The cited source supports part of this claim, but not all of it.
The article reports capital expenditures of $985 million in its Q3 results coverage but does not state the period the figure covers, unlike its other figures, which are explicitly tied to a quarter.
Confirmed in the source:
- Core Scientific's capital expenditures totaled $985 million, as reported alongside its Q3 2026 results
We could not confirm this from the cited source:
- The $985 million capital expenditure figure covers the third quarter alone rather than a longer period such as year-to-date
That does not mean it is false — only that this source does not establish it, as of the date above. If we find a source that settles it, we will re-check and update this page.
What we did: Read our cached copy of the publisher (https://www.tokenpost.com/news/business/50231) in full (2,602 characters, retrieved November 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific Revenue Climbs to $232.9 Million on Colocation Growth - TOKENPOST
Quote: “Capital expenditures totaled $985 million.”